Rimma Driscoll
Rimma Driscoll is an executive in Global Business Development and Strategic Alliances with 20+ years in the field. Rimma has a depth of experience in a broad range of global transactions including JVs,Strategic Alliances, Collaborations, Acquisitions, Divestitures, Licensing Deals, and Partnerships. This experience span from small Discovery deals to multi-billionaire dollar divestitures. Rimma guides Multi-function teams on the external strategies and then leads all aspects of negotiations, and leverages external relationships to bring transactions to closure. She has worked extensively in Pharmaceuticals, Consumer Healthcare and Consumer Products businesses.
Michelle Haven
Justine Conway
John W. Dombrosky
John W. Dombrosky serves as Chief Executive Officer (CEO) of Agtech Accelerator. Launched in 2016 with a consortium of leading venture and industry strategic investors, Agtech Accelerator identifies, forms, capitalizes, and builds from scratch the most promising early-stage agricultural technology companies. The Agtech Accelerator team exclusively focuses on series seed to series a company creation across the ag and food tech economic value system.
Prior to joining Agtech Accelerator, Mr. Dombrosky spent eight years at Syngenta, where his responsibilities spanned licensing, mergers and acquisitions, strategic planning, and business unit leadership roles. In addition to his experience in the agriculture sector, Mr. Dombrosky developed a deep understanding of software and value-added information platforms at Thomson Reuters while serving in finance, business development, and mergers & acquisition roles. Fostering his lifelong fascination with speed and flight, Mr. Dombrosky’s first professional job was as a corporate planning analyst at northwest airlines.
Mr. Dombrosky earned a Bachelor of Arts in financial management from the University of St. Thomas and an MBA from the University of Notre Dame.
Chris Robillard
Chris has spent the last 3 years in business development at Karyopharm helping to advance clinical stage products to commercialization in both the human and animal oncology settings. Karyopharm has tested multiple products in canine oncology, both to inform clinical design in humans and to seek partners to advance products in canine oncology. Chris has spent the over 10 years in pharma/biotech in various business development and financial roles.
Sharon Chase
Dr. Sharon Chase is a small animal veterinarian with over a decade of clinical practice experience gained from working in general and emergency hospitals in Massachusetts and Washington, DC. In addition to clinical practice, Dr. Chase served as a reviewer with the Food and Drug Administration's Center for Veterinary Medicine (CVM) for over seven years. She currently works as a regulatory consultant for the veterinary pharmaceutical industry with Schafer Veterinary Consultants, based in Fort Collins, Colorado.
